by Alan McCann | Jun 22, 2016 | Uncategorized
Researchers at the School of Medicine have developed a possible treatment for lymphedema, the severe swelling of an arm or leg that can occur when the lymph system is blocked. Using scaffolding composed of specially patterned collagen nanofibers, the researchers...
by Alan McCann | Apr 7, 2016 | Uncategorized
Wins $30,000 first place prize among >150 amazing startups in CA event held April 7th at Stanford Medical school. Sponsored by BioSciKin, a Chinese biotech venture focused on precision medicine. See full article at http://califesciences.org/bioscikin-1/. Fibralign...
by Alan McCann | Jan 12, 2016 | Uncategorized
Fibralign’s first product, the BioBridge® Collagen Matrix has received 510(k) clearance from the FDA on January 07, 2016 for use in soft tissue support/repair (K151083). Click to view. BioBridge is a sterile thread-like surgical mesh designed for use in surgery...
by Alan McCann | Jul 7, 2014 | Uncategorized
Michael Paukshto, PhD, CTO and co-founder of Fibralign Corporation, was awarded the 2014 Best New Investigator Award at the 11th Biennial NLN International Conference. Fibralign has developed and established an end-to-end manufacturing system for production of its...
by Alan McCann | Jul 1, 2014 | Uncategorized
Fibralign won the prestigious Medtech Innovator award at the 2014 WSGRC Medical Device Conference, placing first out of over 700 leading MedTech startups for this top honor and $125,000 prize. MedTech Innovator (MTI) is the world’s largest accelerator for...
